THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE Amgen

Georgia rallies, then holds off South Carolina State

Police bust warehouse theft syndicate in BauchiWASHINGTON — Senate Democrats reelected Chuck Schumer as party leader on Tuesday as the party moves into a deeply uncertain time, with no real consensus on a strategy as President-elect Donald Trump prepares to take office. From left, Sen. Elizabeth Warren, D-Mass., Sen. Amy Klobuchar, D-Minn., Senate Majority Leader Chuck Schumer of N.Y., Sen. Dick Durbin, D-Ill., and Sen. Tammy Baldwin, D-Wis., gather after Senate Democratic leadership elections for the next session of Congress on Tuesday in Washington. Schumer faced no opposition in the party leadership elections, in which Illinois Sen. Dick Durbin was also reelected to the No. 2 spot and Minnesota Sen. Amy Klobuchar became the new No. 3. In a statement, Schumer, of New York, said he was honored to move the party forward “during this crucial period for our country.” “Our preference is to secure bipartisan solutions wherever possible and look for ways to collaborate with our Republican colleagues to help working families,” Schumer said. “However, our Republican colleagues should make no mistake about it, we will always stand up for our values.” While Schumer remains popular with his colleagues, it is a bleak moment for Senate Democrats, who were hopeful that they could hold the majority for the third election in a row. Instead they lost four seats and will be in the minority, 53-47, as Trump takes office and pressures the Senate to quickly confirm his Cabinet nominees. Unlike eight years ago, when opposition to Trump’s narrow election win fueled enthusiasm in their party, Democratic lawmakers and many of their voters are exhausted and looking for answers. So far, Democrats have stayed relatively quiet on Trump’s nominees and plans for office – a stark contrast from the loud opposition to Trump when he was elected eight years ago. Schumer has declined to comment on specifics of any nominees, instead allowing Republican reaction to dominate the conversation. On Monday, Schumer wrote a public letter to South Dakota Sen. John Thune, the incoming Republican majority leader, asking him to resist Trump’s pressure to allow him to appoint some of his nominees without a Senate vote and to insist on full FBI background checks for all nominees. But he has said little else about Trump’s upcoming presidency. While some have been more aggressive — Washington Sen. Patty Murray, a former chairwoman of the Senate Health, Labor, Education and Pensions Committee, said that Trump’s nomination of Robert Kennedy Jr. to lead the Health and Human Services Department is “dangerous” and “nothing short of disaster” — several Democratic senators say they are saving their strength and figuring out a focus. “Everybody’s in kind of a wait-and-see mode right now,” said Nevada Sen. Catherine Cortez Masto, who is part of Schumer’s leadership team. “Under the previous Trump administration, there was chaos all the time, all the time. And I do think it is important to pick your battles.” It’s still unclear which battles they will pick. And Democrats have differing opinions on how to fight them. Hawaii Sen. Brian Schatz, who is also in Democratic leadership, says that “anyone who has a grand strategy is full of crap,” but thinks that Democrats, for now, “need to keep things simple.” “We need to talk about people, protect people, advocate for people,” Schatz said. “Do not talk about protecting institutions. Do not talk about advocating for institutions. It’s a not just a rhetorical shift, but an attitudinal shift. We have to remind ourselves, that we’re not fighting for programs and projects and line items and agencies or norms. We’re fighting for people.” Virginia Sen. Mark Warner said that he’s spent a lot of time reflecting, and “I don’t think anyone can claim this was a policy election,” and Democrats need to look at cultural issues. Pennsylvania Sen. John Fetterman says Democrats just need to “pace ourselves” and avoid the “massive freakout” of Trump's last term. Democrats should be preparing, says Connecticut Sen. Richard Blumenthal. He says Schumer is picking his battles “very thoughtfully and strategically.” “We’re thinking about how we protect against using the FBI, or the prosecutorial authority of the Justice Department for retribution against critics,” said Blumenthal. “How we elevate these issues in a way that American people understand them.” Democrats know better now, after eight years, “the extraordinary challenges we’re going to face,” Blumenthal said. Madison Chock and Evan Bates of the U.S. compete in the ice dance rhythm dance program at the Grand Prix of Figure Skating series competition in Tokyo, Japan, Friday, Nov. 8, 2024. (AP Photo/Hiro Komae) A discarded plastic bag floats in the waters of Botafogo beach in Rio de Janeiro, Tuesday, Nov. 26, 2024. (AP Photo/Bruna Prado) China's President Xi Jinping, left center, and Brazil's President Luiz Inacio Lula da Silva, walk into the Alvorada palace after attending a welcoming ceremony in Brasilia, Brazil, Nov. 20, 2024. (AP Photo/Eraldo Peres) Slovakia's Rebecca Sramkova competes against Great Britain's Katie Boulter during a Billie Jean King Cup semi-final match at Martin Carpena Sports Hall in Malaga, southern Spain, on Tuesday, Nov. 19, 2024. (AP Photo/Manu Fernandez) President-elect Donald Trump's nominee to be attorney general, former Rep. Matt Gaetz, R-Fla., closes a door to a private meeting with Vice President-elect JD Vance and Republican Senate Judiciary Committee members, at the Capitol in Washington, Wednesday, Nov. 20, 2024. (AP Photo/J. Scott Applewhite) A surfer rides on an artificial wave in the river 'Eisbach' at the 'Englischer Garten' (English Garden) downtown in Munich, Germany, Monday, Nov. 11, 2024. (AP Photo/Matthias Schrader) A woman carries a gift basket as she arrives at a park to attend a friend's birthday party, Sunday, Nov. 24, 2024, in Kampala, Uganda. (AP Photo/David Goldman) Tania hugs her brother-in-law Baruc after rescuing some of their belongings from their flooded house after the floods in Paiporta, Valencia, Spain, Tuesday, Nov. 5, 2024. (AP Photo/Emilio Morenatti) Democratic presidential nominee Vice President Kamala Harris looks at a monitor backstage, just before taking the stage for her final campaign rally, Monday, Nov. 4, 2024, in Philadelphia. (AP Photo/Jacquelyn Martin) President-elect Donald Trump listens during an America First Policy Institute gala at his Mar-a-Lago estate, Thursday, Nov. 14, 2024, in Palm Beach, Fla. (AP Photo/Alex Brandon) President Joe Biden meets with President-elect Donald Trump in the Oval Office of the White House, Wednesday, Nov. 13, 2024, in Washington. (AP Photo/Evan Vucci) A resident returns to his burned village, Monday Nov. 25, 2024, one day after a fire broke out leaving about 2,000 families homeless at a slum area in Manila, Philippines. (AP Photo/Aaron Favila) Isaac Young rests his cheek on the family horse Rusty's forehead during farm chores before homeschooling, Tuesday, Nov. 12, 2024, in Sunbury, Ohio. (AP Photo/Carolyn Kaster) Students from anti-discrimination movements attack an Awami League supporter in Dhaka, Bangladesh, Sunday, Nov. 10, 2024. (AP Photo/Mahmud Hossain Opu) A young girl holds a "Black Voters for Harris-Walz" sign outside of Democratic presidential nominee Vice President Kamala Harris' election night watch party at Howard University, Tuesday, Nov. 5, 2024, in Washington. (AP Photo/Terrance Williams) A man looks from a damaged building a day after it was hit by a rocket fired from Lebanon, in Ramat Gan, central Israel, Tuesday, Nov. 19, 2024. (AP Photo/Oded Balilty) Visitors walk through the 'Cathedral' on the Christmas light trail as it returns for its12th year with a showcase of new installations set within the UNESCO World Heritage Site landscape of Kew Gardens in London, England, Tuesday, Nov. 12, 2024. (AP Photo/Kirsty Wigglesworth) Venezuelan migrant Alvaro Calderini carries his niece across a river near Bajo Chiquito, Panama, after walking across the Darien Gap from Colombia on their way north to the United States, Saturday, Nov. 9, 2024. (AP Photo/Matias Delacroix) An aerial view shows a packed parking lot at Citadel Outlets in Commerce, Calif., Thursday, Nov. 28, 2024, as early Black Friday shoppers arrive at the mall. (AP Photo/Jae C. Hong) Israeli soldiers holding their weapons bathe with residents in a hot water pool coming from a drilling project which exposed a subterranean hydrothermal spring near Mount Bental in the Israeli-controlled Golan Heights, on the first day of the ceasefire between Israel and Hezbollah, Wednesday, Nov. 27, 2024. (AP Photo/Ohad Zwigenberg) Voters stand in line outside a polling place at Madison Church, Tuesday, Nov. 5, 2024, in Phoenix, Ariz. (AP Photo/Matt York) Molten lava flows on the road to the Blue Lagoon, Grindavik, after the volcanic eruption that started Wednesday, on the Reykjanes Peninsula in Iceland, Thursday, Nov. 21, 2024. (AP Photo/Marco di Marco) Firefighters and sheriff's deputies push a vintage car away from a burning home as the Mountain Fire burns in Camarillo, Calif., on Wednesday, Nov. 6, 2024. (AP Photo/Noah Berger) Supporters of the Frente Amplio (Broad Front) celebrate the victory of candidate Yamandú Orsi in the presidential run-off election in Montevideo, Uruguay, Sunday, Nov. 24, 2024. (AP Photo/Natacha Pisarenko) People gather at the site where former Hezbollah leader Sayyed Hassan Nasrallah was killed by Israeli airstrikes late September during a memorial ceremony in Dahiyeh, in the southern suburb of Beirut, Lebanon, Saturday, Nov. 30, 2024. (AP Photo/Hussein Malla) Katia, 11, with her grandmother and mother sit in an armored minivan during en evacuation by the "White Angels" police unit in Kurakhove, Donetsk region, Ukraine, on Nov. 4, 2024. (AP Photo/Anton Shtuka) People clean mud from a house affected by floods, in Algemesi, Spain, Sunday, Nov. 3, 2024. (AP Photo/Manu Fernandez) Cattle stand on a heap of textile waste at the Old Fadama settlement of Accra, Ghana, Oct. 19, 2024. (AP Photo/Misper Apawu) Family members accompany the coffin that contain the remains of Mexican actress Silvia Pinal, during a memorial service at the Palacio de Bellas Artes, in Mexico City, Saturday, Nov. 30, 2024. Pinal, an actress from Mexico's Golden Age of cinema in the 1940s and 50s, died Thursday. She was 93. (AP Photo/Aurea Del Rosario) A family arrive to cross into Lebanon through the Jousieh border crossing, between Syria and Lebanon, Nov. 28, 2024, following a ceasefire between Israel and Hezbollah that went into effect on Wednesday. (AP Photo/Omar Sanadiki) Respond: Write a letter to the editor | Write a guest opinion Subscribe to stay connected to Tucson. A subscription helps you access more of the local stories that keep you connected to the community. Get Government & Politics updates in your inbox! Stay up-to-date on the latest in local and national government and political topics with our newsletter.

December 2, 1948 - November 19, 2024 Constance J. "Connie" Yeagle, 75, of Bloomington, passed away on November 19, 2024, after a long life of service to others. Connie was born on December 2, 1948, in Bloomington to John C. and Josephine (Arbuckle) Daly. She graduated from Holy Trinity High School and Illinois State University. On December 26, 1970, Connie married Gary M. Yeagle. During their 54 years of marriage, they had six children: Chris Yeagle, Maggie (Joe) Chmiel, Greg (Jessica) Yeagle, Julie Yeagle, Jeff (Katie) Yeagle, and Michael (James) Yeagle. Connie was a devout Catholic whose faith guided all of her decisions. In her final entry into her Gratitude Journal, she wrote: "It isn't about drawing into ourselves. It's about giving yourself away. When you receive someone in love and expect nothing in return, you will become someone new. Jesus says 'Yes, now give yourself away.'" Connie abided by these words throughout her life. In her family life, Connie gave all of herself to her six children. In addition to the tedious tasks of motherhood, such as preparing an estimated 7500 dinners for her large brood, she read books to her children every night, checked their homework, insured they had the most meticulously-executed school projects, and handmade items such candy, clothing, and toys for the holidays. She showed the same level of love and devotion to her grandchildren. Professionally, Connie gave generously to her students. She spent most of her career in adult education, teaching students how to read and prepare for the GED test. She supported her students both in and out the classroom, often babysitting for her student's children and mentoring them after they obtained their GEDs. For her efforts, she won the Arthur J. Stejskal Memorial Teacher of the Year award in 1997. Personally, Connie gave freely to her friends and strangers alike. She had multiple groups of close friends composed of classmates, coworkers, members of her prayer group, and members of her Craft Group. She also volunteered extensively for organizations such as Cursillo, Walk-for-Mankind, and Birthright. Upon retirement, she devoted herself to the Midwest Food Bank and Loaves and Fishes Soup Kitchen. In addition to her generosity, Connie was well known as an excellent dancer, pianist, and seamstress. She was also legendary for her ravenous appetite for books and was recently recognized by the Lexington Public Library for winning the summer reading contest. When Connie was diagnosed with leukemia in January 2022, the kindness she had shown to others came back to her tenfold. Friends and extended family provided constant companionship, kept her refrigerator stocked with food she could eat, took her to medical appointments, and protected her with prayer. Her Craft Group and local cousins were especially invaluable and provided steadfast support. Connie leaves behind one brother, John (Sandy) Daly, Jr.; seven grandchildren, Ben, Madeline, Ian, Olivia, Max, Joelle and Leo; and a long list of beloved nieces, nephews, and cousins. She is predeceased by her parents and one sister, Kathleen Rogers. Her memorial Mass will be held at 10 a.m., Monday, December 2, 2024, at St. Patrick Catholic Church of Merna, Bloomington with Rev. Dustin Schultz officiating. Visitation will be from 1 to 3 p.m., Sunday, December 1, at Carmody-Flynn Funeral Home, Bloomington. In lieu of flowers, memorial donations may be given to Midwest Food Bank, Loaves and Fishes Soup Kitchen, or your favorite charity. To express condolences online, please visit www.carmodyflynn.com . Obituaries Newsletter Sign up to get the most recent local obituaries delivered to your inbox.